Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir, covering 2020-05-18 to 2020-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients [Phase 1, Phase 2]